Literature DB >> 2731652

Expression of a transfected mouse muscle-creatine kinase gene is induced upon growth factor deprivation of myogenic but not of nonmyogenic cells.

J E Johnson1, C L Gartside, J B Jaynes, S D Hauschka.   

Abstract

To determine whether mitogen-regulated expression of skeletal muscle genes is independent of cell type, muscle and nonmuscle cells were transfected with cloned 5'-flanking sequences of muscle creatine kinase (MCK) fused to a heterologous reporter gene and tested for expression in high and low mitogen culture conditions. Consistent with the behavior of endogenous MCK, a -3300MCK-CAT gene is expressed at high levels in differentiated muscle cells but at low to undetectable levels in proliferating myoblasts and in either mitogen-deprived or stimulated nonmuscle cells of mesodermal, ectodermal, or endodermal origin. A -776MCK-CAT gene behaves similarly with respect to its cell type specificity but it supports only an intermediate expression level in response to mitogen deprivation in skeletal muscle cells. These data suggest that the -3300 to +7 nucleotide region of mouse MCK contains one or more elements which are activable by mitogen deprivation only in myogenic cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2731652     DOI: 10.1016/0012-1606(89)90095-x

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  2 in total

1.  Multiple regulatory elements contribute differentially to muscle creatine kinase enhancer activity in skeletal and cardiac muscle.

Authors:  S L Amacher; J N Buskin; S D Hauschka
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

2.  Differentiation and fiber type-specific activity of a muscle creatine kinase intronic enhancer.

Authors:  Phillip Wl Tai; Katherine I Fisher-Aylor; Charis L Himeda; Catherine L Smith; Alexandra P Mackenzie; Deri L Helterline; John C Angello; Robert E Welikson; Barbara J Wold; Stephen D Hauschka
Journal:  Skelet Muscle       Date:  2011-07-07       Impact factor: 4.912

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.